Zevra Therapeutics Inc.

NASDAQ: ZVRA · Real-Time Price · USD
9.28
0.27 (3.05%)
At close: Aug 20, 2025, 3:59 PM
9.38
1.08%
After-hours: Aug 20, 2025, 07:54 PM EDT

Zevra Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
23.61M 27.46M 10.16M 28.65M
Cost of Revenue
7.42M 2.94M 222K 2.06M
Gross Profit
16.2M 24.52M 9.94M 26.59M
Operating Income
-87M -49.6M -42.56M 7.73M
Interest Income
2.17M 4.54M 1.51M 261K
Pretax Income
-90.14M -46.05M -26.8M -8.52M
Net Income
-105.51M -46.05M -26.77M -8.55M
Selling & General & Admin
54.87M 35.09M 15.04M 8.7M
Research & Development
42.09M 39.81M 19.8M 10.16M
Other Expenses
6.24M -775K 17.66M n/a
Operating Expenses
103.2M 74.12M 52.5M 18.86M
Interest Expense
7.35M 1.5M 335K 376K
Selling & Marketing Expenses
n/a n/a -305K n/a
Cost & Expenses
110.61M 77.06M 52.73M 20.92M
Income Tax Expense
15.37M n/a -33K 34K
Shares Outstanding (Basic)
46.25M 35.45M 34.49M 29.77M
Shares Outstanding (Diluted)
46.25M 35.45M 34.49M 29.77M
EPS (Basic)
-2.28 -1.3 -0.78 -2.11
EPS (Diluted)
-2.28 -1.3 -0.78 -2.11
EBITDA
-76.4M -43.54M -25.53M -7.89M
EBIT
-82.79M -44.55M -26.47M -8.14M
Depreciation & Amortization
6.39M 1.01M 944K 257K